Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction

被引:36
作者
Setoguchi, Masahiko [1 ,2 ]
Hashimoto, Yuji [1 ]
Sasaoka, Taro [2 ]
Ashikaga, Takashi [2 ]
Isobe, Mitsuaki [2 ]
机构
[1] Kameda Gen Hosp, Dept Cardiol, Kamogawa, Japan
[2] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan
关键词
Inferior vena cava; Depression; Heart failure with preserved ejection fraction; Readmission; INITIATE LIFESAVING TREATMENT; HOSPITALIZED-PATIENTS; NATRIURETIC PEPTIDE; CLINICAL-OUTCOMES; ORGANIZED PROGRAM; BETA-BLOCKER; OPTIMIZE-HF; PREVALENCE; MORTALITY; DISCHARGE;
D O I
10.1007/s00380-014-0532-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF. We analyzed 310 patients who were hospitalized for the first time with HF. Preserved EF was defined EF a parts per thousand yen50 %, and reduced EF (rEF) was EF < 50 %. The study endpoint was readmission for HF after discharge. Medical history, vital signs, electrocardiograms, chest radiographs, blood tests and echocardiograms were compared between patients with HFpEF and with HFrEF. Among the 142 patients who had HFpEF, 43 reached the endpoint within 1 year. Multivariate analysis revealed depression (HR: 7.185), high brain natriuretic peptide (BNP) levels at discharge (HR: 1.003), and dilated inferior vena cava (HR: 1.100) as independent risk factors for readmission. In contrast, 39 of the 168 patients with HFrEF reached the endpoint. Risk factors for readmission of HFrEF patients were low sodium (HR: 0.856), high blood urea nitrogen (HR: 1.045), high BNP levels at discharge (HR: 1.003) and absence of beta-blocker prescription (HR: 0.395). In conclusion, our study suggests that the predictors of HF readmission differ between HFpEF and HFrEF patients.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
[31]   Heart failure with preserved ejection fraction in Asia [J].
Tromp, Jasper ;
Teng, Tiew-Hwa ;
Tay, Wan Ting ;
Hung, Chung Lieh ;
Narasimhan, Calambur ;
Shimizu, Wataru ;
Park, Sang Weon ;
Liew, Houng Bang ;
Ngarmukos, Tachapong ;
Reyes, Eugene B. ;
Siswanto, Bambang B. ;
Yu, Cheuk-Man ;
Zhang, Shu ;
Yap, Jonathan ;
MacDonald, Michael ;
Ling, Lieng Hsi ;
Leineweber, Kirsten ;
Richards, A. Mark ;
Zile, Michael R. ;
Anand, Inder S. ;
Lam, Carolyn S. P. .
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (01) :23-36
[32]   Diagnosis of Heart Failure with Preserved Ejection Fraction [J].
Wachter, Rolf ;
Edelmann, Frank .
HEART FAILURE CLINICS, 2014, 10 (03) :399-+
[33]   Obesity and Heart Failure with Preserved Ejection Fraction [J].
Koutroumpakis, Efstratios ;
Kaur, Ramanjit ;
Taegtmeyer, Heinrich ;
Deswal, Anita .
HEART FAILURE CLINICS, 2021, 17 (03) :345-356
[34]   Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction [J].
Liu, Dan ;
Hu, Kai ;
Schregelmann, Lena ;
Hammel, Clara ;
Lengenfelder, Bjorn Daniel ;
Ertl, Georg ;
Frantz, Stefan ;
Nordbeck, Peter .
ESC HEART FAILURE, 2023, 10 (02) :1358-1371
[35]   Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction [J].
Malik, Awais ;
Gill, Gauravpal S. ;
Lodhi, Fahad K. ;
Tummala, Lakshmi S. ;
Singh, Steven N. ;
Morgan, Charity J. ;
Allman, Richard M. ;
Fonarow, Gregg C. ;
Ahmed, Ali .
AMERICAN JOURNAL OF MEDICINE, 2020, 133 (01) :84-94
[36]   Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction [J].
Raschi, Emanuel ;
Diemberger, Igor ;
Sabatino, Mario ;
Poluzzi, Elisabetta ;
De Ponti, Fabrizio ;
Potena, Luciano .
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) :303-320
[37]   Exercise Blood Pressure in Heart Failure With Preserved and Reduced Ejection Fraction [J].
Namasivayam, Mayooran W. ;
Lau, Emily M. ;
Zern, Emily A. ;
Schoenike, Mark F. ;
Hardin, Kathryn M. ;
Sbarbaro, John ;
Cunningham, Thomas ;
Farrell, Robyn R. ;
Rouvina, Jennifer C. ;
Kowal, Alyssa ;
Bhat, Rohan E. ;
Brooks, Liana ;
Nayor, Matthew D. ;
Shah, Ravi V. ;
Ho, Jennifer E. ;
Malhotra, Rajeev ;
Lewis, Gregory D. .
JACC-HEART FAILURE, 2022, 10 (04) :278-286
[38]   Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction [J].
Talha, Khawaja M. ;
Butler, Javed .
CLINICAL CARDIOLOGY, 2022, 45 :S31-S39
[39]   Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction [J].
Bishu, Kalkidan ;
Deswal, Anita ;
Chen, Horng H. ;
LeWinter, Martin M. ;
Lewis, Gregory D. ;
Semigran, Marc J. ;
Borlaug, Barry A. ;
McNulty, Steven ;
Hernandez, Adrian F. ;
Braunwald, Eugene ;
Redfield, Margaret M. .
AMERICAN HEART JOURNAL, 2012, 164 (05) :763-U171
[40]   Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults [J].
Zhao, Li ;
Zierath, Rani ;
John, Jenine E. ;
Claggett, Brian Lee ;
Hall, Michael E. ;
Clark, Donald, III ;
Butler, Kenneth R. ;
Correa, Adolfo ;
Shah, Amil M. .
JAMA NETWORK OPEN, 2022, 5 (09) :E2231878